The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease is a research paper published in Journal of Clinical Investigation (2022). On theSindex it has a DataRank of 0. It has been cited 34 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Grant: R01 Al118305,R01 HL140953
NIDCR NIH HHS
Grant: T32 DE017551
NCATS NIH HHS
Grant: UL1 TR001450
NIAID NIH HHS
Grant: R01 AI148403
NCATS NIH HHS
Grant: TL1 TR001451
NCI NIH HHS
Grant: P30 CA138313
National Institutes of Health
Grant: 3UL1TR001450-06S1
South Carolina Clinical & Translational Research Institute (SCTR)
National Institutes of Health
Grant: 2TL1TR001451-06
NRSA Training Core
National Institutes of Health
Grant: 5R01HL118305-03
A Multi-Ethnic Study of Gene-Lifestyle Interactions in Cardiovascular Traits
National Institutes of Health
Grant: 5R01HL140953-04
Targeting IRE-1a/XBP-1 Axis for Control of Chronic GVHD and Leukemia Relapse
National Institutes of Health
Grant: 5P30CA138313-09
Medical University of South Carolina - Cancer Center Support Grant
National Institutes of Health
Grant: 5R01CA258440-04
Targeting PIM-2 Kinase for Improving Cancer Immunotherapy
FWCI
4.59
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals